iFR Assessment of Intermediate Aortic Stenosis Lesions Consolidates

Once a big void that prevented us from effectively assessing functional compromise, intermediate aortic stenosis has made us treat many lesions “just in case”, to save us what would be a complicated procedure, had a valve been placed. Auspiciously, some light has been shed by several, most welcome, studies simultaneously published in J Am Coll Cardiol Intv.

iFR en lesiones no culpables: el momento de la medición parece cambiar la historiaThis study looked at 95 consecutive patients with severe aortic stenosis and intermediate coronary lesions in 116 vessels. It compared invasive iFR with FFR values and non-invasive adenosine stress myocardial perfusion imaging.  

 

Mean iFR was 0.86 (0.76 to 0.93) and FFR was 0.84 (0.76 to 0.91). According to authors, iFR values showed good correlation with FFR values. However, these figures have different clinical implications, seeing as they have different cutoff values. The authors adjusted iFR cut off value to 0.82, but considered standard an FFR cutoff value of ≤0.75. The latter used to be the original value, the one in the DEFER study, one that has been replaced by 0.8 since the FAME trials.


Read also: Safety of Lesion Deferral with iFR or FFR in Both Stable and Acute Patients.


FFR and iFR values also correlated well with perfusion values.

 

Conclusion

According to this study, iFR, FFR, and stress adenosine prefusion values correlate well in patients with severe aortic stenosis. However, this could be misleading: there was no assessment after procedure to check whether values had changed. In this context, rather than changing cutoff index values, it would be easier to measure with iFR alone, since it is not affected by stenosis, compared to FFR which tends to underestimate severity.

 

Original title: Instantaneous Wave-Free Ratio for the Assessment of Intermediate Coronary Artery Stenosis in Patients with Severe Aortic Valve Stenosis. Comparison With Myocardial Perfusion Scintigraphy.

Reference: Futoshi Yamanaka et al.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

We are interested in your opinion. Please, leave your comments, thoughts, questions, etc., below. They will be most welcome.

More articles by this author

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | FLAVOUR II: Angiography-Derived FFR-Guided vs. IVUS-Guided PCI

Physiological assessment is effective when it comes to decision-making for percutaneous coronary intervention (PCI). However, despite the available evidence, its use remains limited. AngioFFR...

ACC-2025 Congress Second Day Key Studies

BHF PROTECT-TAVI (Kharbanda RK, Kennedy J, Dodd M, et al.)The largest randomized  trial carried out across 33 UK centers between 2020 and 2024, assessing...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Patients at High Risk of Bleeding After Coronary Angioplasty: Are Risk Assessment Tools ARC-HBR and PRECISE-DAPT Useful?

Patients undergoing coronary stenting typically receive dual antiplatelet therapy (DAPT) for 6 to 12 months, consisting of a P2Y12 receptor inhibitor and aspirin. While DAPT...

ACC 2025 | WARRIOR: Ischemia in Women with Non-Obstructive Coronary Artery Disease

Approximately half of all women with symptomatic ischemia who undergo coronary angiography are found to have non-obstructive coronary artery disease ((ischemia and non-obstructive coronary...

ACC 2025 | TAVI in Low-Risk Patients: 5-Year Outcomes of EVOLUTE LOW RISK

Transcatheter aortic valve implantation (TAVI) is a valid alternative to surgery in low-risk patients with severe aortic stenosis. However, one of its main limitations...